NASDAQ:XTLB XTL Biopharmaceuticals (XTLB) Stock Price, News & Analysis → This consistently signaled gains of 453%... 610%... and even 1036%... (From Insiders Exposed) (Ad) Free XTLB Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$2.50▼$3.1350-Day Range$3.43▼$5.2052-Week Range$1.73▼$6.69Volume507,746 shsAverage Volume2.22 million shsMarket Capitalization$14.72 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisCompetitorsEarningsHeadlinesShort InterestSocial MediaStock AnalysisCompetitorsEarningsHeadlinesShort InterestSocial Media Get XTL Biopharmaceuticals alerts: Email Address Ad WealthPress$25,000 into $109,616 in two months? Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…Go here to watch the most recent trading workshop video at no charge. About XTL BiopharmaceuticalsXTL Biopharmaceuticals Ltd. engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases. Its pipeline includes hCDR1 and Erythropoietin. The company was founded on March 9, 1993 and is headquartered in Ramat Gan, Israel.Read More Ad Crypto 101 MediaSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. XTLB Stock News HeadlinesMarch 20, 2024 | msn.comU.S. stocks higher at close of trade; Dow Jones Industrial Average up 1.03%March 20, 2024 | msn.comUS Stocks Edge Lower Ahead Of Fed's Decision; General Mills Earnings Top ViewsMarch 28, 2024 | MarketBeat (Ad)Your $200 account credit is about to expireUpdate to MarketBeat All Access and Save $300 on Your Annual SubscriptionMarch 20, 2024 | markets.businessinsider.comDow Surges 350 Points; Fed Holds Rates SteadyMarch 20, 2024 | markets.businessinsider.comCrude Oil Surges 2%; Signet Jewelers Shares Spike HigherMarch 20, 2024 | globenewswire.comXTL To Aquire The Social ProxyFebruary 17, 2024 | investing.comXTL Biopharmaceuticals Ltd ADR (XTLB)October 23, 2023 | finance.yahoo.comXTL Biopharmaceuticals Ltd (H2K2.MU)March 28, 2024 | Crypto Swap Profits (Ad)Did You Get Your Free Bitcoin Yet?And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.October 23, 2023 | finanznachrichten.deXTL Biopharmaceuticals Ltd.: XTL Biopharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price DeficiencyOctober 21, 2023 | finanznachrichten.deXTL Biopharmaceuticals Ltd.: XTL Biopharmaceuticals Confirms that it has not Experienced any Disruption to its Business Operations in IsraelOctober 20, 2023 | finance.yahoo.comXTL Biopharmaceuticals Confirms that it has not Experienced any Disruption to its Business Operations in IsraelOctober 20, 2023 | finance.yahoo.comXTL Biopharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price DeficiencyOctober 1, 2022 | seekingalpha.comXTLB XTL Biopharmaceuticals Ltd.August 8, 2022 | reuters.comX T L Biopharmaceuticals LtdJuly 23, 2022 | seekingalpha.comLIFE, TBLT and XTLB among pre market gainersDecember 15, 2021 | uk.finance.yahoo.comXTL Biopharmaceuticals Ltd. (XTLB)See More Headlines Receive XTLB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for XTL Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today3/28/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:XTLB CUSIPN/A CIK1023549 Webwww.xtlbio.com Phone(729) 955-7080Fax972-3611-6605EmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.42) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-1,350,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-73.05% Return on Assets-68.83% Debt Debt-to-Equity RatioN/A Current Ratio14.09 Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.73 per share Price / Book3.70Miscellaneous Outstanding Shares5,450,000Free Float3,869,000Market Cap$14.72 million OptionableNot Optionable Beta0.96 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesShlomo Spokone ShalevChief Executive Officer & Executive DirectorItay WeinsteinChief Financial OfficerDaphna ParanMedical DirectorKey CompetitorsFlora GrowthNASDAQ:FLGCMIRA PharmaceuticalsNASDAQ:MIRAFortress BiotechNASDAQ:FBIONuCanaNASDAQ:NCNAPurple BiotechNASDAQ:PPBTView All Competitors XTLB Stock Analysis - Frequently Asked Questions When did XTL Biopharmaceuticals' stock split? Shares of XTL Biopharmaceuticals reverse split before market open on Friday, February 10th 2017. The 1-5 reverse split was announced on Wednesday, January 25th 2017. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, February 9th 2017. An investor that had 100 shares of stock prior to the reverse split would have 20 shares after the split. What other stocks do shareholders of XTL Biopharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some companies that other XTL Biopharmaceuticals investors own include Sorrento Therapeutics (SRNE), Supernus Pharmaceuticals (SUPN), VIVUS (VVUS), Akari Therapeutics (AKTX), CymaBay Therapeutics (CBAY), Catalyst Pharmaceuticals (CPRX), Exelixis (EXEL), Gilead Sciences (GILD), Novus Therapeutics (NVUS) and Regulus Therapeutics (RGLS). This page (NASDAQ:XTLB) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersGrab Your Free Bitcoin Today!Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryUrgent: Protect Your Investments from a Chinese InvasionBehind the MarketsSHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding XTL Biopharmaceuticals Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.